Pre-Summit Presentations

Day One Monday October 22
9:00 am - 4:00 pm

The OPEN MINDS Consumer Engagement Technologies Summit

Executive Summit

Can health and human service organizations have a great consumer experience that does not have a digital component? Increasingly, the answer to that question is “no.” Even for the most personal of experiences (dating, banking, shopping, etc.), Americans now expect convenient tech-enabled solutions for all of their activities.

As consumers’ adoption of digital technology in their health service continuum increases, the demand for, and sustainability of, traditional models of service delivery will decrease. Executives need a proactive plan to integrate these new digital technologies into their service system—to both increase consumer preference for their services and decrease service cost.

This summit will review the emerging trends in consumer treatment technologies, explore the new digital treatment options, and discuss how executives of provider organizations can incorporate new technologies into their strategy.

9:00am – 10:15am

Digital Treatment In The Era of Consumerism & Value-Based Care

With the continuous emergence of new technologies, we’re on the verge of moving to an era of digital treatment. These tech tools include everything from mobile apps, to wearable devices, to remote monitoring. In this session, we’ll cover the challenges facing executives as they lead their organization on the path to a tech-driven future – including an examination of the trends driving the inevitability of technology’s prominence in health care; a discussion of the emerging digital technologies currently on the market; and a review of how digital technology will shape your organizations strategy for sustainability.

Deb Adler, Senior Associate, OPEN MINDS

10:30am – 12:00pm

Technology In Action: On-The Ground Perspectives On New Consumer Digital Treatments

For organizations exploring tech-enabled consumer tools, it can be a challenge in determining what distinguishes an “interesting” service from one that has impact and is an operational success. Beyond meeting basic operating requirements, technology selection should be based on your organization's strategy and goals for the future, and how those new technologies contribute to your organization's market advantage. This session will include presentations from organizations that have successfully made consumer treatment technologies part of their organization's strategy.

Deb Adler, Senior Associate, OPEN MINDS

12:00pm – 1:30pm


Sponsored by Mozzaz



1:30pm – 3:00pm

Technology In Action: The Provider Organization Perspective On Consumer Technologies

Implementing a new technology can have far-reaching implications for an organization’s clinical operations, financial sustainability, and consumer relationships. Digital treatment technologies need to be integrated into existing treatment protocols, clinical teams need to accept and learn to excel in using these new tools, and consumers need to feel comfortable and empowered to play a new role in their care. In this session, we’ll hear from organizations who have successfully incorporated consumer technologies into their programing – including their planning process; how they rolled out their new tech for staff and consumers; their program outcomes and future plans; and their advice for organizations considering making new tech investments.

Deb Adler, Senior Associate, OPEN MINDS

Bruce L. Bird, Ph.D., President & Chief Executive Officer, Vinfen

Janelle Wesloh, LADC, MBA, Vice President of Clinical Excellence, Innovation and Recovery Management, Hazelden Betty Ford Foundation

Michelle A. Blackmore, Ph.D., Project Director, Montefiore Medical Center

3:00pm – 4:00pm

The Future Of Consumer Digital Technologies: A Town Hall Discussion Session

There is no doubt that consumer treatment technologies will, eventually, change how health and human services are delivered in some very fundamental ways; but there is a long road between the current state of technology adoption and that future. In this interactive discussion session, our panel will discuss how technology is shaping the current consumer market and their perspectives on the future of digital treatment technology.


Deb Adler

Senior Associate, OPEN MINDS

Deb Adler brings more than 20 years of experience in executive health care roles, serving in a variety of capacities including network executive, quality management executive and chief operating officer, to the OPEN MINDS team.

Her consultant work with OPEN MINDS spans a broad range of customers (provider organizations, payors and government programs) and topics, including: collaborative care models/medical behavioral integration, provider network functions– contracting, network designs/tiering, recruitment, telehealth network implementation, and strategic planning. In addition, Ms. Adler has a special interest in helping technology-enabled providers in “go-to-market” strategies and streamlining network functions.

Since entering the managed behavioral health care field, she has become an industry-recognized leader in value-based contracting and alternative payment models. An innovator known for her ability to execute results, she has facilitated network designs and benefit plan approaches that achieve both quality outcomes and healthcare cost savings.

Before joining OPEN MINDS, Ms. Adler served as Senior Vice President of Network Strategy for Optum (part of UnitedHealth Group) where she was responsible for behavioral health network development, contracting, and strategy for over 185,000 providers. In this role she developed the largest, performance-tiered behavioral health network, largest telemental health network, and largest medication assisted treatment (MAT) network. She was also responsible for implementing network initiatives to promote medical/behavioral integration, improve member outcomes, and reduce total cost of care through collaborative care models.

Prior to joining Optum/UnitedHealth, Ms. Adler spent over 12 years with ValueOptions, Inc. (now Beacon Options) where she held a variety of senior leadership roles including, Executive Vice President of National Networks; Chief Executive Officer, Health Plan Division; Vice President, Network Operations; Executive Director, Corporate Quality Management; and Executive Director, Quality & Information Systems. She was responsible for quality management and coordinated NCQA and URAC accreditation efforts.

Ms. Adler spent her early career in health care quality, serving as a quality director in two state-run psychiatric centers.

Ms. Adler received her Master’s degree in educational psychology and evaluation from Catholic University of America and is a Certified Professional in Health Care Quality (CPHQ).


Bruce L. Bird, Ph.D.

President & Chief Executive Officer, Vinfen

Bruce L. Bird joined Vinfen in 2003 as COO, and has served as President and CEO since 2010.  Vinfen is a large non-profit community behavioral health and disability service company, which in FY 2019 will provide services to about 9000 individuals with a budget of about $188M and a staff of over 3600 throughout locations in Eastern Massachusetts and Connecticut.

Dr. Bird lists several areas of focus at Vinfen, including developing an Innovation Center which: has established and is continuing to operate a community behavioral health home with sustained year over year growth in funding though the Massachusetts Duals Demonstration program; participated with academic institutions (including Harvard and Dartmouth) and software companies in 4 publicly and 9 privately funded technology evaluation projects; partnered with 7 other community organizations and contracting with 14 healthcare ACO/MCO systems to provide health home care coordination services in the new Massachusetts Medicaid Healthcare reform program.

Dr. Bird serves on numerous statewide policymaking and provider organizations and is active in legislative and policy advocacy, including serving as the current vice-chair of the board of the Association of Behavioral Healthcare of Massachusetts.  He is a licensed psychologist, has served on the faculty of the Johns Hopkins Medical School and the associate faculty of the Harvard Department of Psychiatry, and is currently involved in several formal technology research evaluation projects.


Janelle Wesloh, LADC, MBA

Vice President of Clinical Excellence, Innovation and Recovery Management, Hazelden Betty Ford Foundation

Janelle Wesloh, LADC, MBA, Vice President of Clinical Excellence, Innovation & Recovery Management at the Hazelden Betty Ford Foundation has been in the addiction treatment field for 27 years. Wesloh has held many roles, including youth counselor, intake counselor, continuing care counselor, electronic medical record designer, and privacy officer.

She currently provides integration and standardization support to clinical operations across the organization to ensure the optimal functioning of a national system of care. She strives to further establish HBFF's clinical innovation function and helps Hazelden Betty Ford continue to lead the field through research and design. She oversees the Recovery Management division that provides ongoing recovery support through online, phone, and in-person programs and services.

Wesloh is a licensed alcohol and drug counselor; she has an undergraduate degree in psychology with an emphasis in chemical dependency counseling, and an MBA from Hamline University.


Michelle A. Blackmore, Ph.D.

Project Director, Montefiore Medical Center